Journal of Vascular Medicine & Surgery

Abstract

Venous Thromboembolism: Beyond Anticoagulation

Alexandra Moran Baird

The management of Venous Thromboembolism (VTE) has
undergone a remarkable transformation over the past decade,
transitioning from a relatively uniform approach centered on
vitamin K antagonists to a nuanced paradigm incorporating
novel oral anticoagulants, advanced interventional techniques,
and risk-stratified treatment algorithms. Despite these advances,
VTE remains a significant cause of morbidity and mortality,
affecting approximately 900,000 Americans annually and
causing 100,000 deaths. As our understanding of VTE
pathophysiology has evolved, so too has our appreciation for the
heterogeneity of this disease process and the need for
individualized therapeutic strategies.

Published Date: 2025-04-30; Received Date: 2025-03-31